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The earliest steps of embryonic development involve important changes in chromatin and transcription factor
networks, which are orchestrated to establish pluripotent cells that will form the embryo. DNAmethylation, his-
tone modiﬁcations, the pluripotency regulatory network of transcription factors, maternal factors and newly
translated proteins all contribute to these transitions in dynamic ways. Moreover, these dynamics are linked to
the onset of zygotic transcription. We will review recent progress in our understanding of chromatin state and
regulation of gene expression in the context of embryonic development in vertebrates, in particular mouse,
Xenopus and zebraﬁsh. We include work on mouse embryonic stem cells and highlight work that illustrates
how early embryonic dynamics establish gene regulatory networks and the state of pluripotency.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction: routing fertilized eggs to pluripotency
At the very beginning of embryonic development two specialized
and highly differentiated cells, the gametes, fuse to form the zygote
which in turn produces all cell types of the organism (as well as extra-
embryonic tissue in the case of mammals, see below). The parental
genomes show different histone modiﬁcation patterns and are subject
to dramatic chromatin reorganization, DNA demethylation and
remethylation after fertilization and during early development, in
order to reprogram the sperm and oocyte epigenomes [1–7]. Early in
development a maternal to zygotic transition (MZT) is triggered,
which passes regulatory control of development from maternal to
newly synthesized components [8,9]; this regulatory event can be
deﬁned as the period of time encompassing the initial degradation of
maternal transcripts, zygotic genome activation (ZGA, the onset of
transcription), until the ﬁrst major morphological requirement for
zygotic transcripts in embryonic development [9]. Following the ZGA,
pluripotent cells emerge which will give rise to the three germ layers
of the embryo, ectoderm, mesoderm and endoderm, however the rela-
tionship between ZGA and pluripotency is different between mammals
and non-mammalian vertebrates (Fig. 1, Table 1).
In amniotic species such as mammals, the zygote starts transcribing
its own genes just before the two-cell stage. Subsequently,
trophectoderm and primitive endoderm, cell lineages that contribute
to placental development, are set up in addition to the pluripotent
cells of the inner cell mass of the blastocyst that will form the organism
(Fig. 1). Therefore the mammalian zygote is referred to as totipotent,
being able to produce all cell types of both the embryo proper and
embryonic placental tissues [10].
Although early embryonic development is strikingly different in
Xenopus and zebraﬁsh compared to mouse, pluripotency and subse-
quent germ layer commitment, patterning and convergent extension
are functionally highly analogous in these species. In Xenopus and
zebraﬁsh early cleavage development produces a blastula embryo,
which undergoes ZGA (Fig. 1). This is also referred to as the mid-
blastula transition (MBT) [8,9,11]. Cell cycle lengthening and the acqui-
sition of cell motility coincidewith the onset of embryonic transcription
at theMBT [11] and at this stage, at and immediately after theMBT, cells
at the animal pole of the embryo are pluripotent (Fig. 1). These cells are
normally fated to give rise to ectoderm (epidermal ectoderm andneural
ectoderm) but can also give rise to mesoderm and endoderm deriva-
tives when exposed to speciﬁc factors [12].
Pluripotency, as it emerges from the zygote, represents a functional
cellular state, much in the same way differentiated cells have a deﬁned
set of biochemical and cellular properties. These properties emerge
from a cell type-speciﬁc reading of the genomic sequence information,
which is part of what is referred to as epigenetic regulation. At the
molecular level this involves chemical modiﬁcations of either the DNA
itself (for example methylation of cytosine residues) or the chromo-
somal proteins associated with genomic DNA (chromatin). The proﬁles
of epigenetic modiﬁcations can vary between cells and developmental
stages and form a molecular regulatory intermediate between genomic
sequence information and biochemical and cellular properties of cells.
Epigenetics therefore constitutes a developmental stage- and cell
type-speciﬁc ﬁlter of genomic sequence information.
In this review we compare vertebrate studies on the pluripotent
chromatin state and how it emerges during embryonic development.
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We will discuss DNA methylation, histone modiﬁcations, cis-
regulatory elements and transcription factors that prime the zygote
for pluripotency. We will illustrate the ﬁndings from mouse, frog
and ﬁsh embryo models but also discuss ﬁndings in cellular models
of pluripotency such asmouse embryonic stem (ES) cells where war-
ranted. ES cells represent stable pluripotency in vitro, whereas em-
bryonic pluripotency is transitory. However much has been learned
from these systems that also is highly relevant for pluripotency
in vivo. The reader is referred to excellent reviews for other aspects
of pluripotent chromatin and embryogenesis, including more
detailed discussions of the MZT [8,9], chromatin interactions and
complexes [13–17], and naive and primed pluripotency in cell
culture [18,19].
2. Global DNA methylation dynamics in relation to pluripotency
2.1. DNA methylation dynamics in mammalian development
DNAmethylation is an important epigeneticmodiﬁcationwith a role
in a variety of processes, including tissue-speciﬁc gene expression,
development and cellular differentiation, carcinogenesis and aging,
and speciﬁcally for mammals, genomic imprinting and X chromosome
inactivation [20–22]. Methylation at the 5-position of cytosine (5mC)
occurs mainly at CG dinucleotides (commonly referred to as CpG
dinucleotides) in vertebrates and is a prerequisite for normal embryo-
genesis; the DNA methyltransferases DNMT1, DNMT3a and DNMT3b
are all essential for early mouse development [23,24]. DNAmethylation
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Fig. 1.Embryonic development in relation to zygotic gene activation (ZGA) and pluripotency inmouse (toppanel),Xenopus (middle panel) and zebraﬁsh (bottompanel). ZGA occurs at the
late 1-cell stage in mouse, but does not happen until the 12th and 10th cell cycle in Xenopus and zebraﬁsh respectively. In mouse, before pluripotency is established two other lineages,
trophectoderm and primitive endoderm, need to be formed. The inner cell mass (ICM) epiblast cells of the pre-implantation blastocyst (mouse, 3.5 days, red cells) represent the ground
state of pluripotency in vivo, whereas in day 6 embryos (still before gastrulation) these cells have been primed towards differentiation. InXenopus, vegetal pole cells have beenmaternally
speciﬁed to form endoderm and secrete signals to induce mesoderm in the marginal zone. Animal pole cells (red) correspond to the pluripotent cells of the mid-blastula embryo. Times
post-fertilization are indicated for X. laevis at 22 °C. In zebraﬁsh, themid-blastula transition (MBT) starts two cell cycles earlier. Zebraﬁsh has one large yolk cell which does not divide. The
nuclei fromblastodisc cells closest to the yolk cell form a syncytiumwith the yolk cell. This region has amesendodermal fate. Zebraﬁsh times post-fertilization are temperature-dependent
and indicated at 28.5 °C.
Table 1
Overview of early development and pluripotency inmouse, Xenopus and zebraﬁsh. Note the interspeciﬁc differences in the relationship between (1) zygotic genome activation (ZGA) and
pluripotency and (2) DNA methylation and pluripotency. Abbreviations: hypoM, hypomethylated; hyperM, hypermethylated; deM, demethylated; ND, not determined.
Mouse Xenopus Zebraﬁsh
ZGA stage 2 cells Blastula 512 cells
Pluripotent stage Blastocyst (E3.5) Blastula 512 cells
Global DNA methylation hypoM at ZGA and pluripotency hyperM at ZGA and pluripotency hyperM at ZGA and pluripotency
Paternal DNA methylation hyperM, active deM after fertilization ND hyperM, maintained
Maternal DNA methylation Relatively hypoM, passive deM ND Relatively hypoM, hyperM after 16-cell stage
Histone H3 methylation ZGA and later ZGA and later ZGA and later
Pluripotency transcription factors OCT4 (POU5F1)
SOX2
NANOG
Oct91, -25, -60 (Pou5f3)
Sox2
Ventx1, -2
Oct4 (Pou5f3)
Sox2, Sox19b
Nanog
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can be reversed passively (lack of maintenance during DNA replication)
and by members of the ten-eleven translocation (TET) family of 2OG-
Fe(II) dioxygenases which catalyze the hydroxylation of 5mC to gener-
ate 5-hydroxymethylcytosine (5hmC),which can be furthermodiﬁed to
5-formylcytosine and 5-carboxylcytosine and subsequently can be
removed by base excision repair [13,25–27].
DNA methylation in somatic cells portrays a bimodal conﬁguration,
in which the majority of CpG sites are methylated; unmethylated
CpGs are primarily found in clusters, known as CpG islands (CGIs),
which are frequently associated with gene promoters [28,29]. Two-
thirds of gene promoters in mammals are associated with CGIs. 5hmC
signatures are enriched at sites of DNaseI hypersensitivity, which are
indicative of genomic regions bound by regulatory proteins, whereas
5mC is generally much less abundant at these locations. 5hmC is partic-
ularly enriched near transcription start sites and at active and poised
enhancers.
In mouse the paternal genome derived from sperm shows 80 to 90%
overall CpGmethylation but is almost completely demethylated shortly
after fertilization (Table 1) [30,31]. TET3, which is abundant in oocytes
and zygotes, plays an important role in this active demethylation
process by oxidizing 5mC, which is then passively lost during subse-
quent rounds of replication [32–34]. TET1 is not required for
pluripotency and development, although its loss causes a decrease
of 5hmC levels in ES cells and a skewed differentiation toward
trophectoderm in vitro, suggesting a role in inner cell mass speciﬁcation
[35–37]. In addition, loss of TET1 causes skewed differentiation and
allows ES cells to colonize the placenta in embryo chimeras [38]. TET2
is important formaintaining active chromatin at theHoxa cluster during
differentiation [39]. Knockdown of Tet1 and Tet2 reduces the expression
of pluripotency-related genes including Esrrb, Prdm14 and Klf2 [40].
Whereas the paternal genome is actively demethylated in a TET3-
dependent fashion, the maternal genome shows lower global methyla-
tion levels (40%) and undergoes replication-dependent (passive)
demethylation, leading to the observed epigenetic asymmetry [41]. In
this way the early mouse totipotent zygote is devoid of DNA methyla-
tion except at imprinted regions. Erasure of gametic methylation
patterns and genomic remethylation are not required for pluripotency.
Although the genome of DNMT3a, DNMT3b, and DNMT1 triple-
knockout mouse ES cells is hypomethylated, these cells retain self-
renewal and pluripotency but exhibit a host of differentiation defects
[42]. The global demethylation may contribute to a relatively open
and accessible pluripotent chromatin state.
2.2. DNA methylation dynamics in non-mammalian vertebrates
Promoters in non-mammalian species tend to be much less CpG-
dense and many do not meet the general sequence criteria of CGIs,
but like mammalian CGI promoters they contain a cluster of
unmethylated CpG dinucleotides and they also have a similar core
promoter architecture [43–45].
In zebraﬁsh the oocyte methylome is signiﬁcantly hypomethylated
compared to sperm, similar to mammals [46,47]. The zygote shows an
average of the DNA methylation levels of sperm and oocytes immedi-
ately after fertilization, which gradually increases to the level observed
in sperm by the MBT (Table 1). Genes which, against the general
trend, are hypermethylated in oocytes, are demethylated during early
development [47], showing that both the generally hypomethylated
oocyte genome as well as speciﬁc hypermethylated oocyte genes are
remodeled to a sperm-like proﬁle during early embryogenesis. Impor-
tantly, maternal haploid embryos remodel their epigenome to a
sperm-like pattern, showing that thepaternalmethylome is not instruc-
tive for maternal methylome remodeling [47]. By the time of ZGA and
the emergence of pluripotent cells the zebraﬁsh embryonic genome is
relatively hypermethylated with no major changes before and after
the onset of transcription. This is in striking contrast to the mouse
genome which is globally hypomethylated by the time of ZGA, to be
remethylated during pre-implantation development [7]. Another differ-
ence is the extent of methylome remodeling. Early reports indicated an
absence of global demethylation in both ﬁsh and frogs [48,49] and the
remodeling of the maternal methylome identiﬁed in recent zebraﬁsh
studies indeed does not lead to global demethylation but affects speciﬁc
sequences [46,47].
In Xenopus, genomic DNA in sperm as well as embryos of early
blastula and later stages are globally hypermethylated [44,49]. Deple-
tion of maternal dnmt1 by antisense RNA during cleavage stages is asso-
ciated with a decrease in the genomic 5mC content and leads to the
activation of zygotic transcription approximately two cell cycles earlier
than normal [50]. Hypomethylation allows the early expression of
mesodermal and organizer genes such as t (brachyury), cerberus, and
otx2, which are subsequently down-regulated during gastrulation of
the dnmt1-depleted embryos. However, Dnmt1-dependent gene re-
pression was subsequently found to be independent of its catalytic
activity, suggesting that Dnmt1 can also act as a potent transcriptional
repressor independent of DNA methylation [51].
Of the three TET family members in mammals, only two (tet2 and
tet3) are present in the Xenopus genome [52]. In contrast to mouse, in
which Tet3 is abundant in oocytes and zygotes and contributes to active
demethylation of sperm DNA, frog tet3 is extremely low in oocytes and
cleavage stage embryos, consistentwith an absence of global demethyl-
ation in Xenopus early development. Tet3 expression increases after
the MBT and peaks at neurula and neural tube stages. Knockdown
experiments showed that Tet3 and its catalytic activity are important
for neural development and the expression of neural and eye genes [52].
In summary, these data point to a major difference in global DNA
methylation dynamics between vertebrates (Table 1). Whereas the
mouse genome is globally demethylated from ZGA through the
pluripotency at the blastocyst stage, the zebraﬁsh genome is not
globally demethylated in early development and is hypermethylated
during ZGA and pluripotency. Data on DNA methylation is more lim-
ited in Xenopus, but it is clear that genomic DNA is also globally
hypermethylated during ZGA and blastula stages, similar to the situ-
ation in ﬁsh.
2.3. Direct and indirect reading of DNA methylation
The studies cited above indicate that the temporal paths and the
extent of DNAmethylation remodeling are different betweenmammals
and ﬁsh, and that global hypomethylation is not a conserved aspect of
ZGA or pluripotency among vertebrates. Thismay suggest that, general-
ly, not the demethylated state, but the act of remodeling is signiﬁcant
for early development. DNA methylation is known to recruit methyl
CpG binding proteins, which cause repression of transcription [53].
However, contrary to this general paradigm of DNA methylation-
associated repression, methylated DNA can also recruit many other
proteins including transcriptional activators, andmethylated promoters
can drive active transcription in some cases [53–57]. This diversity in
methylation readout is probably highly regulated. Notable differences
have been observed in DNAmethylation readers inmouse ES cells, neu-
ral progenitor cells (NPCs) and brain tissue. For example, the MBD2-
containing NuRD complex is a reader of 5mC in NPCs and brain, but
not in ES cells [56]. Moreover, in both oocytes and late stage embryos
of Xenopus methylated promoter templates are strongly repressed in
cis, however this is not observed in early blastula and gastrula embryos.
In early embryos CpG-dense methylated promoters drive active
transcription while DNA methylation is maintained. These results
point to a temporal uncoupling of DNA methylation and repression of
transcription during development [44].
Interestingly, in mouse ES cells, global DNA methylation status de-
pends on the culture conditions. When grown in 2i media, the genome
is globally hypomethylated inmuch the sameway as the ICMcells of the
blastocyst, whereas ES cells grown in serumplus LIF are also pluripotent
but relatively hypermethylated and in this respect more similar to the
628 S.S. Paranjpe, G.J.C. Veenstra / Biochimica et Biophysica Acta 1849 (2015) 626–636
mouse epiblast [58,59]. Strikingly, mouse ES cells lacking all three DNA
methyl transferases, DNMT1, DNMT3a and DNMT3b, are viable but
cannot differentiate [42]. These data suggest that DNA methylation is
dispensable for pluripotency but not differentiation.
Interestingly, DNA methylation patterns in ﬁsh, frogs and mammals
can be predicted on the basis of conserved DNA sequence content [60]
and inserting DNA sequences in a deﬁned locus determines their DNA
methylation state in a fashion that depends on CpG density and other
sequence content, including transcription factor motifs [61]. Moreover,
histone modiﬁcations such as the promoter mark H3K4me3 (histone
H3 lysine 4 trimethylation) and the Polycomb mark H3K27me3
(histone H3 lysine 27 trimethylation) are preferentially targeted to
unmethylated regions. The locations of each of these histone modiﬁca-
tions can, like DNA methylation itself, be predicted based on DNA
sequence content [60]. This interaction between the DNA methylome
and histone modiﬁcations raises the possibility that early embryonic
remodeling of the methylome serves other functions than altering the
patterns of methylation-dependent transcriptional repression. Indeed,
remodeling of DNA methylation has been found to inﬂuence active
and repressive histone modiﬁcations in the process of reprogramming
ﬁbroblasts to induced pluripotent stem (iPS) cells [62]. As such,
“indirect reading” of DNA methylation by inﬂuencing other epigenetic
modiﬁcations may have a very strong impact on pluripotency inde-
pendent of the classical function of DNA methylation in repression
of transcription. In addition, remodeling of DNA methylation in
early developmental stages may inﬂuence gene expression at later
stages by a more direct readout of interfering with DNA binding of
transcription factors and targeting transcriptional repression. This
may be very important during differentiation which requires the
DNA methyltransferases [42].
3. Histones and histone modiﬁcations
The major proteins in chromatin are the core histone proteins H2A,
H2B, H3, and H4, which form nucleosome particles. The N-terminal
tails undergo a diverse array of posttranslational modiﬁcations and
regulate the accessibility to the underlying DNA. These modiﬁcations
are deposited and removed by enzymes (‘writers’ and ‘erasers’) and
are recognized by speciﬁc proteins (‘readers’) which causes a variety
of functional outcomes such as transcriptional activation or repression
of genes (reviewed in refs. [20,63–65]). These chromatin states can be
transmitted frommother to daughter cells. Lysine acetylation correlates
with chromatin accessibility, recruitment of speciﬁc proteins and tran-
scriptional activity, whereas lysine methylation can have different
effects depending on which residue is modiﬁed. Both ES cells and
early embryos have a relatively open chromatin with histones showing
relatively high levels of modiﬁcations that are involved in gene activa-
tion such as histone H3 lysine 4 trimethylation (H3K4me3), acetylation
of lysines 9 and 14 (H3K9ac, H3K14ac), and histone H4 acetylation
(reviewed in [65,66]). H3K4me3 is found at active promoters while
methylation of another lysine, H3K36me3, is associated with tran-
scribed chromatin and reﬂects RNAPII activity. In contrast, H3K9me3,
H3K27me3 and H4 lysine 20 (H4K20me3) reﬂect repressive chromatin
states. In ES cells relatively low levels are observed of modiﬁcations
associated with gene repression like histone H3 lysine 9 methylation
(H3K9me2 and H3K9me3) compared with those in differentiated
cells. For example large, megabase scale chromosomal regions marked
with H3K9me2, referred to as large organized chromatin K9 modiﬁca-
tions (LOCKs) are decreased markedly in ES cells: LOCKs decorate 4%
of the genome in ES cells, compared to 10, 31 and 46% respectively in
the brain, differentiated ES cells and liver [67]. These domains depend
on the H3K9 methyltransferase EHMT2 (G9A). Tissue-speciﬁc methyl-
ated K9 domains are associated with tissue-speciﬁc repression of
transcription. These ﬁndings illustrate the relatively open nature of
pluripotent chromatin relative to that of differentiated cells.
3.1. Histone H3 K4 and K27 methylation
Genome-wide epigenomemaps ofmouse ES cells, neural progenitor
cells and embryonic ﬁbroblasts revealed that H3K4me3 andH3K27me3
can be used to uncover expressed, poised or repressed genes, allowing
the proﬁling of cells for lineage potential [68,69]. When these two
modiﬁcations, activating H3K4me3 and repressing H3K27me3, deco-
rate the same genomic location the chromatin is referred to as bivalent
[16]. H3K27 methylation is catalyzed by the Polycomb Repressive
Complex (PRC) 2. PRC1 and PRC2 are among the most extensively
studied histone modifying complexes involved in gene repression.
PRC2 contains SUZ12, EZH2, EED, and RBAP46/48 as core components
and catalyzes H3K27 methylation through the methyltransferase activ-
ity of EZH2. H3K27me2 andH3K27me3 can recruit PRC1,which induces
monoubiquitylation of H2AK119with the ubiquitin ligases RING1A and
RING1B in PRC1. PRC1 and PRC2, however, also have independent
functions. H3K27me3 is a marker for developmentally repressed
genes, typically decorating the promoters and transcription initiation
sites of these genes. Many of its targets encode transcription factors
important for differentiation. The Polycomb group proteins are classical
antagonists of the Trithorax group proteins, which include the H3K4
methyltransferases [15,70].
The remarkable phenomenon of bivalency with opposing H3K4me3
and H3K27me3 modiﬁcations was described ﬁrst in ES cells but was
subsequently found in many other systems [69]. Bivalent domains
have garnered attention because the H3K27me3 mark might help
repress cell lineage-regulatory genes during pluripotency while the
H3K4me3mark could poise these genes for activation upon differentia-
tion. In serum-grown ES cells, most bivalent promoters are transcribed
at very low levels (with some exceptions, such as Klf4, Klf5 and Rex1)
and are considered to be poised for activation by developmental signals.
Inmammals sixmethyltransferase proteins, SET1A, SET1B andMLL1
to MLL4, found in COMPASS-like complexes, are capable of methylating
H3K4 [17]. In ﬁbroblasts, MLL1 is required for the H3K4 trimethylation
of a small subset of promoters, including a subset of Hox genes [71].
Loss of H3K4 methylation at these loci causes reduced levels of
transcription initiation by RNA polymerase II. MENIN, a shared subunit
of both MLL1 and MLL2 complexes, is required for most of H3K4
methylation at Hox loci, whereas this does not depend on the MLL3,
MLL4 or SET1 complexes. In line with these ﬁndings, in mouse ES cells
MLL2 is required for H3K4 methylation of bivalent genes that are also
regulated by H3K27me3, including many of the Hox genes [72,73].
Loss of MLL2, however, has very little effect on gene activation during
ES cell differentiation.
The H3K4me3 and H3K27me3 modiﬁcations are unlikely to occur
on the same histone H3 tail [74]. Two copies of H3 are present in the
nucleosome octamer, however, which could accommodate the two
modiﬁcations. This would correspond to an asymmetrically modiﬁed
nucleosome or asymmetric bivalency, rather than intra-molecular
bivalency (Fig. 2). In heat maps of the genomic distribution of histone
modiﬁcations of bivalent chromatin around transcription start sites, it
is apparent that the H3K4me3-positive center of bivalent promoter
regions contains less H3K27me3 signal compared to ﬂanking regions
[75], suggesting the presence of poly-nucleosomal bivalency (Fig. 2).
In this type of bivalency adjacent nucleosomes contain the opposing
histonemodiﬁcations. In some cases cell populations inwhichbivalency
is observed are heterogeneous. In this case the opposing histone modi-
ﬁcations may be present on the same locus in different cells [76]. This
represents pseudo-bivalency among cells with different patterns of
epigenetic modiﬁcations (Fig. 2). Pseudo-bivalency however cannot
explain the co-occurrence of H3K4 and H3K27 methylation in highly
homogenous cells such as naive pluripotent stem cells [75]. In addition,
mass spectrometry-based analyses of ES cells have indicated that 15% of
mononucleosomes modiﬁed with H3K4me3 also carry H3K27me3 on
the second copy of histone H3 within the nucleosome [77]. Together
these studies suggest that asymmetric, poly-nucleosomal and pseudo-
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bivalency all contribute to the observations of co-occurring H3K4me3
and H3K27me3 in chromatin in ES cells.
Duringmouse early development, both H3K4me3 and H3K27me3
appear from the 2-cell stage onwards (Table 1). In the pre-
implantation blastocyst, the inner cell mass (ICM) contains the plu-
ripotent cells that will give rise to the embryo proper, whereas
trophectoderm and primitive endoderm cells will contribute to
extra-embryonic tissue. Trophoblast stem cells and endoderm stem
cells (cultured cells derived from the embryo) show very little
H3K27 methylation in contrast to ES cells, whereas these cells have
similar levels of H3K4me3 [78]. Similarly, ICM and trophectoderm
show different H3K27me3 levels [79]. Therefore, there is signiﬁcant
H3K27 methylation in mouse ICM cells. The H3K27me3 modiﬁcation
however is not universally abundant in pluripotent cells in vitro.
When mouse ES cells are grown in 2i medium, which causes the
cells to be in a ground state of pluripotency that is less poised to
differentiation, H3K27me3 is much reduced in bivalent domains
compared to cells grown in serum plus LIF [75].
In Xenopus early embryos, bivalent chromatin was observed, but not
as a quantitatively dominant feature [80]. Instead, the marks accumu-
late by and large with different spatio-temporal kinetics during the
time between the MBT and the end of gastrulation. H3K4me3 and
H3K27me3 segregate spatially within the embryo (pseudo-bivalency,
Figs. 2 and 3), reﬂecting localized gene expression in different cells.
Moreover H3K4me3 precedes accumulation of H3K27me3 and classical
bivalency is present at low levels but is not a dominant feature of the
pluripotent chromatin state inXenopus. Interestingly, H3K27me3 nucle-
ates ﬁrst in promoter-distal locations in blastula embryos, before accu-
mulating in larger domains (Fig. 3), highlighting the spatio-temporal
hierarchy of H3K4 and H3K27 methylation during pluripotency and
germ layer induction [60,80]. Consistent with these ﬁndings,
Geminin promotes Polycomb binding and H3K27 methylation and
contributes to the transition from pluripotency to lineage commitment
by preventing multi-lineage commitment [81]. The abundance of
histone modiﬁcations has also been determined by quantitative mass
spectrometry; the results showed relatively abundant H3K4me3 from
early stages on, whereas H3K27me3 accumulated over time and was
much less abundant at any stage compared to mouse ES cells [82].
Bivalent chromatin has been reported in early zebraﬁsh embryos,
immediately after the MBT [83]. Also in zebraﬁsh embryos K4 accu-
mulates ﬁrst, being very abundant at the MBT, with K27 methylation
accumulating signiﬁcantly between the MBT and 50% epiboly (mid-
gastrulation) [84]. These studies have also highlighted the accumula-
tion of H3K4me3 before the MBT and transcriptional activation,
suggesting a role for maternal factors in setting a permissive mark for
transcription in preparation for the pluripotent stage of development.
Fig. 2.Different types of bivalent chromatin. Bivalent chromatin is deﬁned by the co-occurrence of histoneH3 lysine 4 and lysine 27 trimethylation (H3K4me3 andH3K27me3). In the case
of intra-molecular bivalency theywould co-occur on the sameH3 tail; however this is unlikely to happen in vivo (see text). Asymmetric bivalency: Nucleosomes can carry the two histone
modiﬁcations at two different H3 tails within the same nucleosome. Poly-nucleosomal bivalency: Adjacent nucleosomes can carry the opposing histone modiﬁcations. Pseudo-bivalency:
Different cells within a population (or alleles within a cell) carry different histone modiﬁcations. This type is highly relevant in vivowhere pluripotency is a transient and unstable state,
leading to lineage commitment in different cells. H3K4me3 and H3K27me3 are indicated in green and red respectively.
Fig. 3. Histone modiﬁcations and DNA methylation in relation to pluripotency and germ layer induction in Xenopus. Overall the genome is hypermethylated, but both H4K4me3 and
H3K27me3 emerge in unmethylated CpG islands with different kinetics.
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3.2. Enhancer histone modiﬁcation signatures
Enhancers are distinguished from promoters by robust levels of
H3K4me1 while H3K4me3 is absent or very low [85]. In addition they
may be decorated with H3K27 acetylation and feature the recruitment
of RNAPII and the EP300/CBP histone acetyltransferase which catalyzes
H3K27 acetylation. Several hundred thousand enhancers have been
identiﬁed in the human genome by proﬁling these histone modiﬁca-
tions and the transcriptional coactivator EP300 [86–90]. Many of these
enhancers drive cell type-speciﬁc gene expression, for example in ES
cells. Enhancers decorated with both H3K4me1 and H3K27ac are con-
sidered active enhancers, as opposed to primed enhancers only marked
with H3K4me1, and the active enhancer subset ismore predictive of de-
velopmental state than all enhancers [86,90]. In addition, H3K4me1-
positive enhancers may be enriched for H3K27me3 rather than
H3K27ac, which are referred to as poised enhancers. Proﬁling these
histone modiﬁcations in ES cells has uncovered human enhancers that
are poised in ES cells but become active during differentiation [89].
Validation of the activity of these human enhancers in zebraﬁsh embry-
os showed that they are able to direct cell-type and stage-speciﬁc
expression even in the absence of sequence conservation in the ﬁsh ge-
nome. During differentiation a subset of poised enhancers acquires
H3K27 acetylation, RNAPII association and enhancer RNAs. These data
show that developmental enhancers are epigenetically pre-marked
and kept in a poised state during pluripotency. There are indications
that the H3K4me1 mark is important not just for poised or primed
enhancers, but also for active enhancers. For example, the Drosophila
Trr complex and its mammalian MLL3 and MLL4 counterparts are
involved in H3K4 monomethylation at enhancers [91–93]. These
complexes also contain UTX (KDM6A), an H3K27 demethylase which
counteracts PRC2-mediated H3K27 methylation. This is signiﬁcant as
the lysine cannot accommodate both acetylation and methylation
simultaneously. Indeed, loss of Trr/MLL4 leads to global reduction of
H3K27acetylation, implicating the MLL3/4 complexes in the function
of both poised and active enhancers.
Proﬁling of enhancers in Xenopus blastula embryos using H3K4me1
uncovered many enhancers, a subset of which recruited RNAPII, and
another partially overlapping subset recruited the PRC2 catalytic
subunit Ezh2 and the PRC2-associated factor Jarid2 [60], illustrating
the dynamic balance of opposing activities present on enhancers during
pluripotency. In zebraﬁsh, changes in H3K27 acetylation enrichment
accompany a shift from pluripotent to tissue-speciﬁc gene expres-
sion [94]. A marked increase in the number of enhancers was observed
from the dome stage (blastula) to 80% epiboly (gastrula). This illustrates
the high complexity of gene expression associated with germ layer
speciﬁcation and patterning. Enhancers that lose H3K27 acetylation at
blastula and gastrula stages are enriched for pluripotency factor
Pou5f1 (Oct4) and Sox2 binding sites, and the majority of them overlap
with genomic peaks of theNanog-like factor at the dome stage [94]. Like
the mammalian pluripotency factors, the zebraﬁsh Nanog-like protein
likely contributes to the pluripotent program and its down-regulation
or eviction could facilitate developmental progression.
3.3. Histone variants and linker histones
The histone proteins are highly conserved; however there are nonal-
lelic variants of themajor histones that show a divergence ranging from
almost no amino acid differences to signiﬁcant changes. Localized
replacement of a canonical histone with a variant can alter chromatin
state. Among the core histones, H2A has the largest number of variants,
including H2A.Z, MacroH2A, H2A-Bbd, H2AvD, and H2A.X [95–97].
H2A–H2B dimers can be replaced by several different H2A variants
independently of replication. Histone variant incorporation is one of
the mechanisms to create different states through a combination of al-
tered chromatin structure or trans-acting factors. For instance, depletion
of H2A.Z leads to reduced chromatin accessibility with a decrease in the
binding of both active and repressive complexes and a reduction in the
binding of the pluripotency transcription factor OCT4 to its binding sites
at pluripotency genes. As a consequence the cells showed a reduction
in the efﬁciency of self-renewal [98]. A study investigating the
reprogramming of mammalian nuclei transplanted to Xenopus oocytes
showed that the HIRA-dependent deposition of H3.3 at the oct4 locus
was required for transcriptional reprogramming to a pluripotent state
[99]. Another study in Xenopus investigated the role of H3.3 during
embryonic development. Partial depletion of H3.3 results in abnormal
development, whereas substantial depletion of both H3.1 and H3.3
showed a distinct gastrulation arrest phenotype. Using lineage marker
analyses, the defect was attributed to a loss of competence to respond
to mesoderm inducing cues and this defect was attributed to perturba-
tion in chromatin organization brought about by loss of H3 and abnor-
mal incorporation of linker histone H1A [100]. Replacement of an
oocyte-speciﬁc linker histone by somatic linker histones has been
shown to contribute to a loss of mesoderm competence [101]. The H1
linker histone contributes to silencing of pluripotency factors and par-
ticipates in mediating changes in DNA methylation and histone marks
necessary for silencing of pluripotency genes during differentiation
[102]. These ﬁndings illustrate that the pluripotency gene network
requires both the incorporation and loss of speciﬁc histone variants,
and that remodeling chromatin state plays a role in both establishing
and the exit of pluripotency.
4. Chromatin remodeling
As outlined above, chromatin state is affected bymyriad proteins, in-
cluding enzymes that catalyze the particular chemical modiﬁcations,
proteins that recognize and bind the modiﬁcations, and the enzymes
that remove this modiﬁcation. In addition, chromatin state is affected
by chromatin remodeling complexes that enable context-dependent
access to packaged DNA. Chromatin remodelers act on nucleosomes,
the basic repeating unit of packaged DNA. They use the energy of ATP
hydrolysis to move, destabilize, eject, or restructure nucleosomes and
thereby increase the ﬂuidity of chromatin. There are four families of
nucleosome remodelers [103,104]: (1) SWI/SNF [switching defective/
sucrose nonfermenting], also called BAF [Brg/Brahma- associated
factor]; (2) ISWI [imitation switch]; (3) CHD [chromodomain, helicase,
and DNA binding]; and (4) INO80 [inositol requiring 80]. All these
families of nucleosome remodelers are involved in diverse activities,
including transcription, DNA repair, and DNA replication. As such
many subunits of the complexes are essential for the maintenance of
pluripotency and proliferation of ES cells.
The SWI/SNF (BAF) complexes of mammals contain either BRM or
BRG1 as nucleosomal ATPase subunits. Whereas BRM is dispensable
for mouse development, BRG1 is essential for inner cell mass and
trophectoderm survival and preimplantation development [105].
esBAF is an ES cell-speciﬁc SWI/SNF complex, characterized by subunits
BRG1, BAF155 and BAF60A, and the absence of BRM, BAF170, and
BAF60C. esBAF is required for the maintenance of pluripotency. Like
BRG1, BAF155 is important for preimplantation development, mainte-
nance of Oct4 expression and proliferation of ES cells [106]. In ES cells,
knockdown of BRG1 has been shown to downregulate pluripotency
genes and upregulate differentiation genes. BRG1 not only occupied
the promoters of pluripotency genes but also occupied a subset of
OCT4, SOX2, NANOG and PcG protein target genes [107]. esBAF is char-
acterized by the presence and absence of speciﬁc subunits and this com-
plex composition has been shown to direct its speciﬁc role in the core
pluripotency network [106]. In murine ES cells, esBAF has been shown
to be involved in a complex regulatory circuitry. BRG1-esBAF functions
positively with PcG to repress differentiation genes (all four Hox loci),
but prevents PcG mediated repression of pluripotency genes activated
by ES cell transcription factors like OCT4, SOX2 and STAT3 [108].
CHD11 is necessary for the maintenance of open chromatin in ES
cells [109]. Knockdown of Chd1 increases heterochromatin in ES cells
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and reduced Oct4 expression. Surprisingly this knockdown decreased
the expression of only 25 genes, suggesting a functional redundancy
with other chromatin remodeling complexes. A much larger group
of genes was upregulated upon Chd1 knockdown, including genes
involved in neurogenesis. Although ES cells with Chd1 knockdown can
maintain an undifferentiated state, the cells lose the ability to differen-
tiate into primitive endoderm and tend to differentiate into neural
lineages, indicating that CHD1 is necessary for the maintenance of
pluripotency [109]. More recently CHD1 has been speciﬁcally implicat-
ed in maintaining high levels of RNAPI and II in transcribing protein-
coding genes and ribosomal DNA, thereby sustaining the transcriptional
competence of pluripotent cells [110].
Nucleosome remodeling deacetylase (NuRD) complexes contain
Mi2 (Chd3/Chd4) nucleosomal ATPase, as well as methyl-CpG-binding
proteins MBD2 or MBD3, histone deacetylase and a number of other
subunits. This complex is the most abundant source of histone
deacetylase in Xenopus eggs and early embryos [111]. Mouse ES cells
lacking MBD3 are viable but cannot differentiate properly and show
LIF-independent self-renewal [112]. A functional NuRD complex has
been implicated in maintaining transcriptional heterogeneity in ES cell
populations by inhibiting pluripotent gene expression and promoting
exit from pluripotency [113]. Several hundred genes show increased
expression in MBD3 knockdown, decreased expression in BRG1
knockdown and a wild-type like expression in double knockdowns,
uncovering their opposing effects [114]. Unlike ES cells, MBD3-
deﬁcient blastocyst ICM cells grown ex vivo fail tomaintain a population
of Oct4-positive pluripotent cells [115]. On a similar note, MBD3 is re-
quired for reprogramming and the derivation of induced pluripotent
stem (iPS) cells [116]. Depleting MBD3/NuRD complex in somatic cells
impairs somatic cell reprogramming by establishing heterochromatic
features and repression of key pluripotency genes [117].
Like esBAF, the INO80 nucleosome remodeling complex is found
at pluripotency genes along with Oct4, Sox2 and Nanog [118]. It medi-
ates the recruitment of RNAPII andmaintains open chromatin structure
in ES cells as shown bymicrococcal nuclease and DNAseI hypersensitiv-
ity assays. Knockdown of Ino80 causes a decreased expression of
pluripotency factors and a loss of ES cell morphology. Expression of
Ino80 is important for iPS cell colony formation. Knockdown of Ino80
in early embryos caused impaired blastocyst formation and reduced ex-
pression of pluripotency factors in the ICM [118]. The role of chromatin
remodeling in Xenopus and zebraﬁsh pluripotency has yet to be deter-
mined. In mouse, the results discussed above illustrate how mobiliza-
tion of nucleosomes and/or nucleosome eviction at gene-regulatory
regions is required for development and maintenance of pluripotency.
5. The pluripotency transcription factor network
The concomitant actions of cis- and trans-acting elements orches-
trate the early developmental programs, inﬂuencing the cascade of
events that leads to functional pluripotency. In this sectionwewill high-
light how transcription factors control the emergence of pluripotency.
5.1. The core pluripotency network in ES cells
OCT4, SOX2 andNANOG forma “core” network of pluripotency tran-
scription factors [119,120]. They are co-recruited to regulatory elements
of target genes and form auto-regulatory and feedforward loops
that provide stability to pluripotency gene expression and suppress
lineage-speciﬁc gene expression. These factors regulate each other and
process signals to direct self-renewal and block differentiation bymain-
taining the expression of the pluripotency network. Thebinding of these
transcription factors is transduced by the mediator complex to recruit
general transcription factors to the promoter, which promote the re-
cruitment of RNAPII complex. The mediator subunit MED12 interacts
with Nanog and these factors work together in ES cell gene regulation
[121]. In addition to the well-characterized core network of OCT4,
SOX2 and NANOG, an additional set of transcription factors, including
ESRRB, TFCP2L1, KLF2, and KLF4, makes important contributions to
the pluripotent regulatory circuitry and can reset human ES cells to
ground-state pluripotency [122,123]. Three KLF transcription factors,
KLF2, KLF4 and KLF5, share many transcriptional targets with NANOG
and regulate Nanog and other pluripotency genes [124].
Mouse ES cells cannot only be grown in 2i or serum plus LIF condi-
tions, conditions that correspond to naive (ground-state) and primed
pluripotent states, they can also be primed by exposure to FGF2 and
activin, leading to the formation of a transient epiblast-like cells
(EpiLCs). ES cells and EpiLCs share the core transcription network of
OCT4, SOX2, and NANOG. The transition between these two pluripotent
states, however, is associated with widespread OCT4 relocalization ac-
companied by global rearrangement of enhancer chromatin landscapes
[125]. Motif analyses suggested OTX2 and ZIC2/3 as mediators of
primed pluripotency-speciﬁc OCT4 binding. Blocking differentiation
signals and overexpressing OTX2 was sufﬁcient to drive exit from the
naive state and induce transcription of several primed pluripotency
genes. OTX2 drives the early stage of ES cell differentiation in collabora-
tion with OCT4 at enhancers [126]. ZIC3 is an activator of NANOG and
contributes to maintenance of pluripotency in mouse ES cells [127,
128], but in zebraﬁsh and Xenopus embryos it functions in neural and
neural crest gene expression [129,130]. Epiblast stem cells (EpiSCs)
are derived directly from developing mouse epiblast embryos; a subset
of these cells express OCT4 in addition to SOX2. However EpiSCs also
express post-implantation markers and show heterogeneous expres-
sion of lineage speciﬁc genes of mesendoderm, deﬁnitive endoderm
and the primitive streak [131,132].
The transcription initiation factor TBP and many of its associated
factors (TAFs) of the TFIID complex are expressed at higher levels in
mouse ES cells than in somatic cells. Knockdown of these factors affect-
ed the pluripotent circuitry leading to inhibition of reprogramming of
ﬁbroblasts. Transient expression of TFIID subunits greatly enhanced
reprogramming showing that TFIID is critical for transcription factor-
mediated reprogramming and the maintenance of pluripotency [133].
5.2. Embryonic pluripotency transcription factors in non-mammalian
vertebrates
The oct4 gene (pou5f1) has been duplicated early in the vertebrate
lineage, giving rise to pou5f1 and pou5f3 [134]. Some vertebrates, for
example marsupials and sharks, have retained both copies, whereas
mammals have lost pou5f3 (Table 1). Both teleost ﬁsh and frogs have
lost the other copy, pou5f1, but retained pou5f3. Additionally, there are
three tandem-duplicated oct4-like pou5f3 genes in Xenopus: oct91
(pou5f3.1) which is not expressed in the oocyte but is induced at the
MBT, oct25 (pou5f3.2) which is maternal but not translated until after
fertilization, and oct60 (pou5f3.3) which is exclusively maternally
expressed [135]. Sox2 is present in the Xenopus genome, but there is
no clear orthologue of Nanog. Its activity may be taken over by ventx1
and ventx2, which are closely related and structurally and functionally
very similar to Nanog. Loss of these factors leads to down-regulation
of oct91 and premature differentiation, suggesting that these factors
play a Nanog-like role in amphibian development [136].
InXenopus tropicalis, the zygotic genome activates in a broadwave of
new transcription extending from the 7th cleavage division (early
blastula) to beyond the 12th cleavage division (MBT) [137]. The Oct25
protein levels increase dramatically in early development and Oct25 is
with 400 million copies per embryo among the most abundant
transcription factors at the early gastrula stage [138]. Oct25 represses
Nodal andWnt signaling and antagonizes the T-box transcription factor
Vegt, thereby antagonizing mesoderm induction [139,140]. Nodal-
responsive enhancers are marked with H3K4me1 and H3K27ac at the
blastula stage, independent of zygotic Nodal signaling [141]. Foxh1
mediates Nodal signaling together with Smad2/3, but also functions
independently and co-occupies Oct25 targets, which may modulate
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the transition between pluripotency and mesendoderm induction
[142]. In both mouse ES cells and Xenopus embryos neural differentia-
tion requires Suv4-20h (Kmt5b/c) to repress Oct25, illustrating the
necessity to down-regulate the pluripotency network upon exit of
pluripotency [143].
Two studies in zebraﬁsh have highlighted the role of the
pluripotency network in early development and zygotic genome activa-
tion (ZGA). In zebraﬁsh ZGA coincides with the stage of embryonic
pluripotency. Using ribosome proﬁling it was found that zebraﬁsh
Nanog, Pou5f3 (a homolog of the mammalian pluripotency transcrip-
tion factor OCT4, also referred to as Pou5f1) and SoxB1 (related to
Sox2) are the most highly translated transcription factors just before
zygotic genome activation sets in [144]. Pou5f3 is recruited to Sox2-
POU binding sites before the MBT, and similarly Nanog binds to
promoters of ﬁrst wave expression genes. Combined loss of these
factors resulted in developmental arrest before gastrulation and a fail-
ure to activate many embryonic genes [144,145]. These data link ZGA
to the pluripotency network in zebraﬁsh. This may be different from
the situation in mouse, as genetic removal of OCT4 frommouse oocytes
does not affect ZGA, totipotency–pluripotency and developmental
competence [146,147].
6. Long non-coding RNA
RNA is an integral component of chromatin and plays a role in the
pluripotent regulatory circuitry. Large intergenic non-coding RNAs
(lincRNAs) have been identiﬁed in ES cells [148], and shRNA loss of
function experiments showed that 137 of 147 lincRNAs affected the
expression of an average of 175 protein-coding genes in trans
[149]. Of these, 15 lincRNAs were found to be important for the ex-
pression of multiple pluripotency markers and ES cell morphology.
In addition lincRNAs were found to repress gene expression related
to endoderm, (neuro-)ectoderm, mesoderm and trophectoderm dif-
ferentiation, thereby maintaining pluripotency. Many regulatory se-
quences of these lincRNAs are bound by Oct4, Nanog and Sox2.
Moreover, many of the lincRNAs interact with chromatin modifying
enzymes, interacting with chromatin readers, writers and erasers,
including the Polycomb complexes PRC1 and PRC2 [149]. PRC2 has
also been found to interact with cis-acting RNA; at loci where these
RNAs are made by RNAPII. Although this contributes to targeting
of the complex, enzymatic activity seems to require the PRC2-
associated factor Jarid2 [150,151].
One lincRNA named TUNA was shown to be highly expressed when
mouse ES cells differentiated toward the neural lineages. TUNA deple-
tion inhibited neural differentiation. TUNA was shown to occupy
promoter regions of Nanog, Sox2, and Fgf4, genes that are important
for pluripotency and neural lineage commitment [152].
The DNAmethyltransferase Dnmt1 also interacts withmany cellular
transcripts, including the extra-coding CEBPA lincRNA [153]. This
lincRNA adopts a stem-loop structure critical for interaction with
Dnmt1 and when transcribed, acts to shield the Cebpa locus from DNA
methylation. This study provides another line of evidence establishing
how cells employ RNAs to modulate the deposition of repressive epige-
netic marks in a genome-widemanner [153]. TheWDR5 subunit ofMLL
complexes also interacts with RNA, includingmany lincRNAs important
for ES cell pluripotency. WDR5 RNA binding activity is speciﬁcally
required for H3K4 methylation and maintenance of pluripotency in ES
cells [154]. These data highlight that non-coding RNAs, some of which
are transcribed under the control of the pluripotency regulatory
network, can act in cis or in trans to maintain pluripotency and repress
lineage speciﬁc gene expression, and they do so, at least in part, by
interactions with chromatin-modifying complexes. Developmental
stage-speciﬁc lincRNAs have been identiﬁed in Xenopus and zebraﬁsh
embryos [155–159], but their role in establishing pluripotency has not
been determined.
7. Perspective
By its very nature embryonic development is highly dynamic, and it
is no surprise that many of the underlying molecular processes are dy-
namic as well. At its many different levels of organization, DNAmethyl-
ation, chromatin composition, histone modiﬁcations acting at diverse
genomic elements, and transcription factor networks are all acting
within their own molecular logic to orchestrate development. As illus-
trated above, there are integral links between zygotic genomeactivation
and the cellular state of pluripotency. In a simple scenario, exempliﬁed
by zebraﬁsh, the core pluripotency network is instrumental for the
onset of embryonic transcription while establishing the pluripotent
state at the same time. In mouse, the zygote activates its genome, but
ﬁrst needs to produce the extra-embryonic lineages as well as the
pluripotent cells of the inner cell mass of the blastocyst. Despite these
differences, accumulating evidence summarized in this review
shows that a great deal of functional conservation is apparent in
the pluripotency network.
One of the major current challenges is to elucidate the interplay
between different layers of regulation that together instruct vertebrate
development. In recent years, techniques like ChIP-sequencing, RNA-
sequencing, and proteomics have been applied to ES cells, their differen-
tiated derivatives, and embryos of mouse, Xenopus, zebraﬁsh and many
others. Ongoing efforts in these areas should allow elucidating systems
biology views of the regulatory networks in each of these model sys-
tems. These highly fruitful endeavors will provide further insight in
the differences and similarities of pluripotency in the embryo, in culture
and in different species.
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